Abstract:Dengue is endemic in Vietnam with circulation of all four serotypes (DENV1-4) all year-round. It is hard to estimate the disease's true serotype-specific transmission patterns from cases due to its high asymptomatic rate, low reporting rate and complex immunity and transmission dynamics. Seroprevalence studies have been used to great effect for understanding patterns of dengue transmission. We tested 991 population serum samples (ages 1–30 years, collected 2013 to 2017), 531 from Ho Chi Minh City and 460 from Khanh Hoa in Vietnam, using a flavivirus protein microarray assay. By applying our previously developed inference framework to the antibody profiles from this assay, we can (1) determine proportions of a population that have not been infected or infected, once, or more than once, and (2) infer the infecting serotype in those infected once. With these data, we then use mathematical models to estimate the force of infection (FOI) for all four DENV serotypes in HCMC and KH over 35 years up to 2017. Models with time-varying or serotype-specific DENV FOI assumptions fit the data better than constant FOI. Annual dengue FOI ranged from 0.005 (95%CI: 0.003–0.008) to 0.201 (95%CI: 0.174–0.228). FOI varied across serotypes, higher for DENV1 (95%CI: 0.033–0.048) and DENV2 (95%CI: 0.018–0.039) than DENV3 (95%CI: 0.007–0.010) and DENV4 (95%CI: 0.010–0.016). The use of the PMA on serial age-stratified cross-sectional samples increases the amount of information on transmission and population immunity, and should be considered for future dengue serological surveys, particularly to understand population immunity given vaccines with differential efficacy against serotypes, however, there remains limits to what can be inferred even using this assay. Dengue is endemic in Vietnam and this virus consists of four serotypes (DENV1-4) that circulate- all year-round. It has complex transmission and immunity dynamics, which makes serotype-specific transmission patterns difficult to estimate. Moreover, high asymptomatic rates which leads to under reporting and little serotype testing of cases adds to this issue. Many studies have shown that seroprevalence studies are useful to understanding dengue transmission patterns, hence, we undertook a seroprevalence studies in Ho Chi Minh City and Khanh Hoa, Vietnam. We tested samples using a flavivirus protein microarray (PMA) serological assay and used previously developed frameworks to estimate past infection exposures for each individual. With these past exposure histories, we estimated the transmission intensity for all four dengue serotypes. We found this method provided substantial information on past serotype transmission. We estimated the annual dengue force of infection (FOI) ranged from 0.005 (95%CI: 0.003–0.008) to 0.201 (95%CI: 0.174–0.228). FOI varied across serotypes, higher for DENV1 (95%CI: 0.033–0.048) and DENV2 (95%CI: 0.018–0.039) than DENV3 (95%CI: 0.007–0.010) and DENV4 (95%CI: 0.010–0.016). This method can be used for planning future control measures, especially vaccination.

Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam's South-central coast: a cross-sectional study

The Seroprevalence, Waning Rate, and Protective Duration of Anti-Diphtheria Toxoid IgG Antibody in Nha Trang, Vietnam.

The seroprevalence of toxocariasis and related risk factors in children in Ho Chi Minh City, Vietnam: results from a school-based cross-sectional study

Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination

Sero and Carriage Epidemiology of Pertussis in Urban and Rural Regions in Vietnam

Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China

Australian vaccine preventable disease epidemiological review series: diphtheria 1999-2019

Seroprevalence of Diphtheria and Tetanus Immunoglobulin G among the General Health Population in Guangzhou, China

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines

Estimating the force of infection of four dengue serotypes from serological studies in two regions of Vietnam

Pertussis seasonal variation in Northern Vietnam: the evidence from a tertiary hospital

Dengue virus serotypes and related factors in children with dengue hemorrhagic fever in Southern Vietnam

Parents' Attitude about Hepatitis B Disease and Practice of Hepatitis B Vaccination among Children in Ho Chi Minh City, Vietnam

Factors affecting childhood immunization in Lao People's Democratic Republic: a cross-sectional study from nationwide, population-based, multistage cluster sampling

Understanding Parental Decision-Making and Determinants of COVID-19 Vaccination for Children in Vietnam: A Cross-Sectional Online Survey

Dengue Hemorrhagic Fever in Quang Nam Province (Vietnam) from 2020 to 2022-A Study on Serotypes Distribution and Immunology Factors

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report

The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria–Tetanus–Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity

Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand

Effect of Pneumococcal Conjugate Vaccine on Prevalence of Otitis Media with Effusion among Children in Vietnam.

Immunity to Non-Dengue Flaviviruses Impacts Dengue Virus Immunoglobulin G Enzyme-Linked Immunosorbent Assay Specificity in Cambodia